Fischer Medical Ventures Intrinsic Value

Fischer Medical Ventures intrinsic value. Fischer Medical Ventures (FISCHER) median intrinsic value is ₹45.72 from 3 valuation models (range ₹7–₹57), vs current price ₹22.86 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. For current market price and key ratios, visit Fischer Medical Ventures share price today.

Market Price (CMP)
₹22.86
Primary Intrinsic Value
₹57.15
Market Cap
₹150.9 Cr
+100.0% Upside
Median Value
₹45.72
Value Range
₹7 - ₹57
Assessment
Trading Below Calculated Value
Safety Margin
50.0%

FISCHER Valuation Methods Summary — DCF, Graham Number & P/E

Fischer Medical Ventures intrinsic value across 3 models vs current price ₹22.86 — upside/downside and value range per method. Browse FISCHER balance sheet details for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹57.15 ₹51.44 - ₹62.87 +150.0% Book Value/Share: ₹58.33, P/B: 1.0x
Revenue Multiple Method revenue ₹45.72 ₹41.15 - ₹50.29 +100.0% Revenue/Share: ₹59.39, P/S: 0.8x
Dividend Yield Method dividend ₹6.86 ₹6.17 - ₹7.55 -70.0% DPS: ₹0.05, Target Yield: 3.5%
Method Types: Earnings Asset DCF Growth Dividend Conservative

FISCHER Intrinsic Value vs Market Price — All Valuation Models

Fischer Medical Ventures fair value range ₹7–₹57 vs current market price ₹22.86 across 3 valuation models. Analyse FISCHER shareholding pattern to track promoter, FII and institutional holdings.

FISCHER Intrinsic Value Analysis — Undervalued or Overvalued?

Fischer Medical Ventures median intrinsic value ₹45.72, current price ₹22.86 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.

What is the intrinsic value of FISCHER?

Based on our comprehensive analysis using 3 different valuation methods, the estimated intrinsic value of Fischer Medical Ventures (FISCHER) is ₹45.72 (median value). With the current market price of ₹22.86, this represents a +100.0% variance from our estimated fair value.

The valuation range spans from ₹6.86 to ₹57.15, indicating ₹6.86 - ₹57.15.

Is FISCHER undervalued or overvalued?

Based on our multi-method analysis, Fischer Medical Ventures (FISCHER) appears to be trading below calculated value by approximately 100.0%.

FISCHER Financial Health — Key Ratios vs Industry Benchmarks

Fischer Medical Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity -12.5% Industry Standard: 15%+ Below 10% Measures shareholder return efficiency
Operating Margin -4.0% Industry Standard: 20%+ Below 10% Indicates operational efficiency level
Asset Turnover Ratio 0.58x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

FISCHER Cash Flow Quality — Operating & Free Cash Flow

Fischer Medical Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹-101 Cr ₹-104 Cr Negative Cash Flow 3/10
March 2025 ₹-86 Cr ₹-149 Cr Negative Cash Flow 3/10
March 2024 ₹-7 Cr ₹-22 Cr Negative Cash Flow 3/10